Guo-Yuan Yang Selected Research

Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)

1/2022	Oligodendrocyte precursor cell transplantation promotes angiogenesis and remyelination via Wnt/β-catenin pathway in a mouse model of middle cerebral artery occlusion.
2/2021	Transcranial Focused Ultrasound Stimulation Improves Neurorehabilitation after Middle Cerebral Artery Occlusion in Mice.
1/2021	BK Channel-Mediated Microglial Phagocytosis Alleviates Neurological Deficit After Ischemic Stroke.
1/2021	M2 microglial small extracellular vesicles reduce glial scar formation via the miR-124/STAT3 pathway after ischemic stroke in mice.
1/2020	P2Y6 receptor inhibition aggravates ischemic brain injury by reducing microglial phagocytosis.
1/2020	Response by Pan and Yang to Letter Regarding Article, "MicroRNA-126-3p/-5p Overexpression Attenuates Blood-Brain Barrier Disruption in a Mouse Model of Middle Cerebral Artery Occlusion".
1/2020	Fingolimod Inhibits Inflammation but Exacerbates Brain Edema in the Acute Phases of Cerebral Ischemia in Diabetic Mice.
1/2020	MicroRNA-126-3p/-5p Overexpression Attenuates Blood-Brain Barrier Disruption in a Mouse Model of Middle Cerebral Artery Occlusion.
10/2019	Dl-3-N-butylphthalide attenuates ischemic reperfusion injury by improving the function of cerebral artery and circulation.
1/2019	Rapamycin Increases Collateral Circulation in Rodent Brain after Focal Ischemia as detected by Multiple Modality Dynamic Imaging.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo-Yuan Yang Research Topics

Disease

55	Ischemic Stroke 09/2022 - 04/2008
44	Brain Ischemia (Cerebral Ischemia) 01/2022 - 09/2003
38	Stroke (Strokes) 05/2022 - 04/2008
35	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 05/2002
34	Ischemia 06/2022 - 05/2002
27	Infarction (Infarctions) 01/2021 - 09/2003
26	Brain Injuries (Brain Injury) 12/2020 - 09/2003
14	Arteriovenous Malformations (Arteriovenous Malformation) 09/2017 - 04/2003
12	Brain Infarction 06/2022 - 03/2012
9	Hypoxia (Hypoxemia) 11/2017 - 04/2004
8	Atrophy 06/2022 - 04/2010
8	Inflammation (Inflammations) 12/2021 - 04/2004
8	Brain Edema (Cerebral Edema) 01/2020 - 12/2011
7	Cerebral Hemorrhage 01/2020 - 09/2007
7	Aneurysm (Aneurysms) 01/2018 - 06/2008
6	Edema (Dropsy) 09/2022 - 07/2013
6	Hemorrhage 02/2020 - 05/2005
5	Brain Diseases (Brain Disorder) 09/2022 - 01/2006
5	Vascular Diseases (Vascular Disease) 11/2017 - 08/2004
5	Neoplasms (Cancer) 01/2017 - 01/2003
4	Thrombosis (Thrombus) 09/2016 - 06/2008
3	Neuroinflammatory Diseases 06/2022 - 09/2018
3	Hypertension (High Blood Pressure) 12/2018 - 09/2006
3	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2018 - 12/2011
3	Cerebral Infarction 01/2018 - 04/2008
3	Intracranial Aneurysm (Cerebral Aneurysm) 01/2018 - 06/2008
3	Hereditary Hemorrhagic Telangiectasia 09/2010 - 02/2004
3	Vascular Remodeling 07/2009 - 03/2007
3	Rupture 03/2009 - 09/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2009
2	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 12/2013
2	Pathologic Constriction (Stenosis) 02/2020 - 06/2008
2	Reperfusion Injury 10/2019 - 01/2018
2	Gliosis 10/2018 - 01/2017
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2018 - 01/2016
2	Cognitive Dysfunction 01/2018 - 03/2010

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
15	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2011
13	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2006
12	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2009
10	CytokinesIBA 01/2020 - 01/2004
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2004
7	Immunoglobulin G (IgG)IBA 09/2022 - 01/2013
6	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2022 - 09/2006
6	Netrin-1IBA 12/2021 - 03/2011
6	erucylphosphocholineIBA 11/2017 - 04/2010
6	Matrix Metalloproteinases (MMPs)IBA 12/2011 - 04/2003
5	Neuroprotective AgentsIBA 09/2022 - 11/2017
5	Messenger RNA (mRNA)IBA 07/2019 - 01/2004
5	Caspase 3 (Caspase-3)IBA 05/2009 - 05/2002
4	Therapeutic UsesIBA 09/2022 - 01/2018
4	Tight Junction ProteinsIBA 01/2020 - 11/2017
4	Evans Blue (Blue, Evans)FDA Link 01/2020 - 12/2011
4	Pharmaceutical PreparationsIBA 01/2019 - 09/2014
4	methylarginyl- lysyl- prolyl- tryptophyl- tert- leucyl- leucyl- ethyl esterIBA 01/2016 - 03/2011
3	Interleukin-10 (Interleukin 10)IBA 02/2021 - 01/2015
3	Peroxidase (Myeloperoxidase)IBA 01/2020 - 06/2008
3	OccludinIBA 01/2020 - 01/2013
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 02/2014
3	Aquaporin 4IBA 12/2018 - 12/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2006
3	Oxygen (Dioxygen)IBA 01/2018 - 01/2006
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 04/2008
3	Bromodeoxyuridine (BrdU)IBA 01/2017 - 10/2015
3	Interleukin-8 (Interleukin 8)IBA 10/2014 - 01/2013
3	EndoglinIBA 09/2010 - 02/2004
3	Activin Receptors (Activin Receptor)IBA 03/2009 - 02/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022 - 03/2009
2	CateninsIBA 01/2022 - 01/2020
2	Myelin Basic ProteinIBA 01/2022 - 10/2015
2	Erythropoietin FDA Link 01/2022 - 01/2016
2	Phosphotransferases (Kinase)IBA 12/2021 - 09/2010
2	Mitogen-Activated Protein Kinase 3IBA 01/2021 - 05/2002
2	p38 Mitogen-Activated Protein KinasesIBA 09/2020 - 12/2016
2	CalciumIBA 05/2020 - 04/2007
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 04/2016
2	VimentinIBA 01/2020 - 10/2018
2	EnzymesIBA 01/2020 - 09/2003
2	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2019 - 01/2016
2	3-n-butylphthalide (butylphthalide)IBA 10/2019 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 12/2017 - 11/2017
2	AdiponectinIBA 11/2017 - 12/2013
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2016 - 01/2013
2	salicylhydroxamic acid (SHAM)IBA 08/2016 - 07/2008
2	Metformin (Glucophage)FDA LinkGeneric 10/2014 - 09/2014
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2014 - 04/2004
2	MelatoninIBA 10/2014 - 01/2014
2	Green Fluorescent ProteinsIBA 10/2014 - 06/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014 - 04/2008
2	Insulin (Novolin)FDA Link 04/2014 - 04/2008
2	Adenosine Triphosphate (ATP)IBA 02/2014 - 04/2004

Therapy/Procedure

42	Therapeutics 05/2022 - 11/2004
20	Transplantation 01/2022 - 08/2005
9	Synchrotrons 12/2019 - 01/2012
7	Sutures (Suture) 09/2017 - 05/2009
5	Lasers (Laser) 01/2019 - 01/2011
3	Suture Techniques 04/2014 - 03/2012
2	Intravenous Injections 01/2022 - 01/2021
2	Injections 04/2017 - 12/2014
2	Microbubbles 09/2016 - 06/2011